AI assistant
Sending…
LIFECORE BIOMEDICAL, INC. \DE\ — Director's Dealing 2017
Jan 20, 2017
33431_dirs_2017-01-20_f4763b7e-f296-4507-add2-918217555251.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LANDEC CORP \CA\ (LNDC)
CIK: 0001005286
Period of Report: 2017-01-18
Reporting Person: HIEBERT LARRY D (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-18 | Common Stock | M | 2500 | $5.63 | Acquired | 12839 | Direct |
| 2017-01-18 | Common Stock | F | 1135 | $12.40 | Disposed | 11704 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-01-18 | Incentive Stock Option (Right to Buy) | $5.63 | M | 2500 | Disposed | 2017-05-26 | Common Stock (2500) | Direct |
More from LIFECORE BIOMEDICAL, INC. \DE\
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Jan 16
Investor Presentation
2025
Nov 17
Interim / Quarterly Report
2025
Nov 6
Earnings Release
2025
Nov 6
Declaration of Voting Results & Voting Rights Announcements
2025
Oct 31
Major Shareholding Notification
2025
Oct 17
Regulatory Filings
2025
Oct 1